BioToday.com [新着ニュース] BioToday.comは医学情報、バイオテクノロジー、バイオベンチャー関連ニュースのデータベースです。 http://www.biotoday.com/news.cfm biotoday@biotoday.com Copyright © 2026 BioToday Ltd. All Rights Reserved. Thu, 21 May 2026 16:55:13 +0900 ja http://blogs.law.harvard.edu/tech/rss [医学] カルシウムやビタミンD補給の骨折や転倒の目ぼしい予防効果なし http://www.biotoday.com/view.cfm?n=109906&ref=rss http://www.biotoday.com/view.cfm?n=109906&ref=rss ジャーナル / 総合医学誌 / BMJ biotoday@biotoday.com Thu, 21 May 2026 16:55:12 +0900 http://www.biotoday.com/post_comment.cfm?init=A109906&ref=rss [医学] トラネキサム酸静注が帝王切開女性の産後出血を減らした http://www.biotoday.com/view.cfm?n=109905&ref=rss http://www.biotoday.com/view.cfm?n=109905&ref=rss ジャーナル / 総合医学誌 / BMJ biotoday@biotoday.com Thu, 21 May 2026 16:43:04 +0900 http://www.biotoday.com/post_comment.cfm?init=A109905&ref=rss [医学] 冠動脈バイパス手術後の抗血小板薬2種併用3か月は1年に劣らず出血率を下げる http://www.biotoday.com/view.cfm?n=109904&ref=rss http://www.biotoday.com/view.cfm?n=109904&ref=rss ジャーナル / 総合医学誌 / BMJ biotoday@biotoday.com Thu, 21 May 2026 16:27:34 +0900 http://www.biotoday.com/post_comment.cfm?init=A109904&ref=rss [医学] アルミニウム添加ワクチンの健康への害は見られず http://www.biotoday.com/view.cfm?n=109903&ref=rss http://www.biotoday.com/view.cfm?n=109903&ref=rss ジャーナル / 総合医学誌 / BMJ biotoday@biotoday.com Thu, 21 May 2026 16:01:04 +0900 http://www.biotoday.com/post_comment.cfm?init=A109903&ref=rss [医学] ベンゾジアゼピン等の睡眠/不安薬を使った妊婦の子の神経発達疾患は多くない http://www.biotoday.com/view.cfm?n=109902&ref=rss http://www.biotoday.com/view.cfm?n=109902&ref=rss ジャーナル / 総合医学誌 / BMJ biotoday@biotoday.com Thu, 21 May 2026 15:46:53 +0900 http://www.biotoday.com/post_comment.cfm?init=A109902&ref=rss [医学] 頭にあてた磁気での左一次運動野（左M1）刺激で自閉症小児の社交が改善 http://www.biotoday.com/view.cfm?n=109901&ref=rss http://www.biotoday.com/view.cfm?n=109901&ref=rss ジャーナル / 総合医学誌 / BMJ biotoday@biotoday.com Thu, 21 May 2026 15:08:12 +0900 http://www.biotoday.com/post_comment.cfm?init=A109901&ref=rss [医学] 難儀な親元を幼い頃に去って里親に引き取られた子はより賢く、健やかになる http://www.biotoday.com/view.cfm?n=109900&ref=rss http://www.biotoday.com/view.cfm?n=109900&ref=rss ジャーナル / 総合医学誌 / BMJ biotoday@biotoday.com Thu, 21 May 2026 14:46:10 +0900 http://www.biotoday.com/post_comment.cfm?init=A109900&ref=rss [企業] Incyte社がGenesis社との人工知能（AI）創薬提携を拡大 http://www.biotoday.com/view.cfm?n=109899&ref=rss http://www.biotoday.com/view.cfm?n=109899&ref=rss ビジネス / 対外交渉 / 企業間提携 biotoday@biotoday.com Thu, 21 May 2026 12:14:30 +0900 http://www.biotoday.com/post_comment.cfm?init=A109899&ref=rss [企業] Immunovantの甲状腺眼症Ph3試験失敗のFcRn阻害薬batoclimab開発打ち切り http://www.biotoday.com/view.cfm?n=109898&ref=rss http://www.biotoday.com/view.cfm?n=109898&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 || 開発 / 臨床試験 / 中止 biotoday@biotoday.com Thu, 21 May 2026 11:49:29 +0900 http://www.biotoday.com/post_comment.cfm?init=A109898&ref=rss [企業] 便秘薬の後発品を遅らせた損害賠償金9億ドル弱の支払いが武田薬品に命じられた http://www.biotoday.com/view.cfm?n=109897&ref=rss http://www.biotoday.com/view.cfm?n=109897&ref=rss ビジネス / トラブル / 訴訟 biotoday@biotoday.com Thu, 21 May 2026 11:27:48 +0900 http://www.biotoday.com/post_comment.cfm?init=A109897&ref=rss [企業] 生後2か月からのPfizerの25価肺炎球菌ワクチンPF07872412接種Ph2試験成績良好 http://www.biotoday.com/view.cfm?n=109896&ref=rss http://www.biotoday.com/view.cfm?n=109896&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 || 開発 / 臨床試験 / 第2相試験 biotoday@biotoday.com Thu, 21 May 2026 11:02:23 +0900 http://www.biotoday.com/post_comment.cfm?init=A109896&ref=rss [企業] ウイルスに依らないDNA核内運搬のEngage Bio社をLillyが最大2億ドル強で買う http://www.biotoday.com/view.cfm?n=109895&ref=rss http://www.biotoday.com/view.cfm?n=109895&ref=rss ビジネス / 対外交渉 / 合併/買収 biotoday@biotoday.com Thu, 21 May 2026 10:44:26 +0900 http://www.biotoday.com/post_comment.cfm?init=A109895&ref=rss [医学] ミトコンドリア外膜がちぎれて作られる小袋が寄生虫の増殖を促す http://www.biotoday.com/view.cfm?n=109891&ref=rss http://www.biotoday.com/view.cfm?n=109891&ref=rss biotoday@biotoday.com Thu, 21 May 2026 10:01:49 +0900 http://www.biotoday.com/post_comment.cfm?init=A109891&ref=rss [医学] United社のTyvasoが特発性肺線維症に効いた米国/カナダPh3試験論文報告 http://www.biotoday.com/view.cfm?n=109894&ref=rss http://www.biotoday.com/view.cfm?n=109894&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 || ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM） biotoday@biotoday.com Thu, 21 May 2026 09:34:11 +0900 http://www.biotoday.com/post_comment.cfm?init=A109894&ref=rss [医学] 救急科の喘鳴幼児への抗生剤アジスロマイシン無効 http://www.biotoday.com/view.cfm?n=109893&ref=rss http://www.biotoday.com/view.cfm?n=109893&ref=rss ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM） biotoday@biotoday.com Thu, 21 May 2026 08:37:15 +0900 http://www.biotoday.com/post_comment.cfm?init=A109893&ref=rss [医学] 大出血患者の病院到着前輸血をO型全血にしても成分輸血に比べて死亡率下がらず http://www.biotoday.com/view.cfm?n=109892&ref=rss http://www.biotoday.com/view.cfm?n=109892&ref=rss ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM） biotoday@biotoday.com Thu, 21 May 2026 07:57:14 +0900 http://www.biotoday.com/post_comment.cfm?init=A109892&ref=rss [医学] 喘息の治療に使われるmontelukastなどのCysLTR1阻害薬が癌治療にも役立ちうる http://www.biotoday.com/view.cfm?n=109890&ref=rss http://www.biotoday.com/view.cfm?n=109890&ref=rss biotoday@biotoday.com Wed, 20 May 2026 16:06:43 +0900 http://www.biotoday.com/post_comment.cfm?init=A109890&ref=rss [企業] 曰く付きのTavneosを患者に新たに使うことを止めるようキッセイ薬品が要請 http://www.biotoday.com/view.cfm?n=109889&ref=rss http://www.biotoday.com/view.cfm?n=109889&ref=rss ビジネス / トラブル / 安全性 biotoday@biotoday.com Wed, 20 May 2026 14:49:55 +0900 http://www.biotoday.com/post_comment.cfm?init=A109889&ref=rss [企業] UCB社のBimzelxが乾癬性関節炎Ph3試験でAbbVieのSkyriziに10%ほどの差で勝利 http://www.biotoday.com/view.cfm?n=109888&ref=rss http://www.biotoday.com/view.cfm?n=109888&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 biotoday@biotoday.com Wed, 20 May 2026 14:00:54 +0900 http://www.biotoday.com/post_comment.cfm?init=A109888&ref=rss [企業] 移植腎臓を助けるHansa社のIgG切断薬imlifidaseの欧州等での権利をSERBが取得 http://www.biotoday.com/view.cfm?n=109887&ref=rss http://www.biotoday.com/view.cfm?n=109887&ref=rss ビジネス / 対外交渉 / ライセンス biotoday@biotoday.com Wed, 20 May 2026 12:23:51 +0900 http://www.biotoday.com/post_comment.cfm?init=A109887&ref=rss [医学] Apnimed社の睡眠時無呼吸の飲み薬AD109の効果を裏付けたPh3試験論文報告 http://www.biotoday.com/view.cfm?n=109886&ref=rss http://www.biotoday.com/view.cfm?n=109886&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 biotoday@biotoday.com Wed, 20 May 2026 11:15:36 +0900 http://www.biotoday.com/post_comment.cfm?init=A109886&ref=rss [企業] PIK3CA変異血管奇形患者の6割の病変がRelay社のPI3Kα阻害薬で20%以上縮小 http://www.biotoday.com/view.cfm?n=109885&ref=rss http://www.biotoday.com/view.cfm?n=109885&ref=rss 開発 / 臨床試験 / 第2相試験 biotoday@biotoday.com Wed, 20 May 2026 10:57:38 +0900 http://www.biotoday.com/post_comment.cfm?init=A109885&ref=rss [企業] SanofiのAAT欠損症薬で正常域の働くAAT濃度100%維持〜Wave社も試験結果報告 http://www.biotoday.com/view.cfm?n=109884&ref=rss http://www.biotoday.com/view.cfm?n=109884&ref=rss 開発 / 臨床試験 / 第2相試験 biotoday@biotoday.com Wed, 20 May 2026 10:14:31 +0900 http://www.biotoday.com/post_comment.cfm?init=A109884&ref=rss [医学] マントル細胞リンパ腫のImbruvica込み初治療での自己幹細胞移植の取り柄示せず http://www.biotoday.com/view.cfm?n=109883&ref=rss http://www.biotoday.com/view.cfm?n=109883&ref=rss ジャーナル / 総合医学誌 / Lancet biotoday@biotoday.com Wed, 20 May 2026 08:45:58 +0900 http://www.biotoday.com/post_comment.cfm?init=A109883&ref=rss [医学] 117の低〜中所得国（LMIC）への14の感染症ワクチン提供の成果を推定 http://www.biotoday.com/view.cfm?n=109882&ref=rss http://www.biotoday.com/view.cfm?n=109882&ref=rss ジャーナル / 総合医学誌 / Lancet biotoday@biotoday.com Wed, 20 May 2026 07:12:22 +0900 http://www.biotoday.com/post_comment.cfm?init=A109882&ref=rss [医学] Meiji Seikaのβラクタマーゼ阻害薬nacubactamの取り柄を示したPh3試験論文報告 http://www.biotoday.com/view.cfm?n=109881&ref=rss http://www.biotoday.com/view.cfm?n=109881&ref=rss ジャーナル / 総合医学誌 / Lancet biotoday@biotoday.com Tue, 19 May 2026 15:12:24 +0900 http://www.biotoday.com/post_comment.cfm?init=A109881&ref=rss [医学] Rocheの抗ST2抗体astegolimabが負け越した慢性閉塞性肺疾患Ph2b/3試験論文 http://www.biotoday.com/view.cfm?n=109880&ref=rss http://www.biotoday.com/view.cfm?n=109880&ref=rss ジャーナル / 総合医学誌 / Lancet biotoday@biotoday.com Tue, 19 May 2026 13:40:18 +0900 http://www.biotoday.com/post_comment.cfm?init=A109880&ref=rss [医学] 落ちた体重をLillyの経口薬FoundayoやGLP-1/GIP薬tirzepatide低用量で維持しうる http://www.biotoday.com/view.cfm?n=109879&ref=rss http://www.biotoday.com/view.cfm?n=109879&ref=rss ジャーナル / 総合医学誌 / Lancet biotoday@biotoday.com Tue, 19 May 2026 13:19:13 +0900 http://www.biotoday.com/post_comment.cfm?init=A109879&ref=rss [企業] Ipsenの長く効く神経阻害薬のしわ取り効果が6割の患者で半年持続 http://www.biotoday.com/view.cfm?n=109878&ref=rss http://www.biotoday.com/view.cfm?n=109878&ref=rss 開発 / 臨床試験 / 第2相試験 biotoday@biotoday.com Tue, 19 May 2026 12:11:40 +0900 http://www.biotoday.com/post_comment.cfm?init=A109878&ref=rss [企業] BioMarin社のくる病の一種ENPP1欠損症薬BMN401がPh3試験の目標の1つを逃す http://www.biotoday.com/view.cfm?n=109877&ref=rss http://www.biotoday.com/view.cfm?n=109877&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 biotoday@biotoday.com Tue, 19 May 2026 10:47:13 +0900 http://www.biotoday.com/post_comment.cfm?init=A109877&ref=rss [企業] Merck & CoのTROP2標的抗体sac-TMTがPh3試験で子宮内膜癌患者の生存改善 http://www.biotoday.com/view.cfm?n=109876&ref=rss http://www.biotoday.com/view.cfm?n=109876&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 biotoday@biotoday.com Tue, 19 May 2026 10:29:42 +0900 http://www.biotoday.com/post_comment.cfm?init=A109876&ref=rss [企業] 手のつけようがなかった的狙いの治療をRegeneronがParabilisと組んで開発する http://www.biotoday.com/view.cfm?n=109875&ref=rss http://www.biotoday.com/view.cfm?n=109875&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 biotoday@biotoday.com Tue, 19 May 2026 09:49:08 +0900 http://www.biotoday.com/post_comment.cfm?init=A109875&ref=rss [企業] AstraZenecaの降圧薬Baxfendy/バックスフェンディを米国承認 http://www.biotoday.com/view.cfm?n=109874&ref=rss http://www.biotoday.com/view.cfm?n=109874&ref=rss 開発 / 承認申請 / 承認取得 biotoday@biotoday.com Tue, 19 May 2026 08:54:14 +0900 http://www.biotoday.com/post_comment.cfm?init=A109874&ref=rss [企業] RegeneronのLAG-3阻害薬fianlimab頼みの黒色腫（メラノーマ）治療Ph3試験失敗 http://www.biotoday.com/view.cfm?n=109873&ref=rss http://www.biotoday.com/view.cfm?n=109873&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 biotoday@biotoday.com Tue, 19 May 2026 08:38:32 +0900 http://www.biotoday.com/post_comment.cfm?init=A109873&ref=rss [企業] 中国の太り過ぎ/肥満成人の体重がVincentage社の経口GLP-1薬で12%ほど低下 http://www.biotoday.com/view.cfm?n=109872&ref=rss http://www.biotoday.com/view.cfm?n=109872&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 biotoday@biotoday.com Tue, 19 May 2026 07:24:21 +0900 http://www.biotoday.com/post_comment.cfm?init=A109872&ref=rss [医学] 肥満の人の割合は高所得国の多くで落ち着き、中〜低所得国の多くでは上昇 http://www.biotoday.com/view.cfm?n=109871&ref=rss http://www.biotoday.com/view.cfm?n=109871&ref=rss biotoday@biotoday.com Mon, 18 May 2026 13:04:20 +0900 http://www.biotoday.com/post_comment.cfm?init=A109871&ref=rss [医学] 目の光合成でドライアイ治療 http://www.biotoday.com/view.cfm?n=109870&ref=rss http://www.biotoday.com/view.cfm?n=109870&ref=rss biotoday@biotoday.com Mon, 18 May 2026 11:10:13 +0900 http://www.biotoday.com/post_comment.cfm?init=A109870&ref=rss [医学] RemeGen社のBLyS/APRIL阻害薬telitaciceptのIgA腎症Ph3試験で蛋白尿6割弱低下 http://www.biotoday.com/view.cfm?n=109869&ref=rss http://www.biotoday.com/view.cfm?n=109869&ref=rss ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM） biotoday@biotoday.com Sun, 17 May 2026 15:58:04 +0900 http://www.biotoday.com/post_comment.cfm?init=A109869&ref=rss [医学] Regenxbio社の遺伝子治療の運び役のAAVがPLAG1遺伝子に割り込んで癌が発生 http://www.biotoday.com/view.cfm?n=109868&ref=rss http://www.biotoday.com/view.cfm?n=109868&ref=rss ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM） biotoday@biotoday.com Sun, 17 May 2026 13:19:28 +0900 http://www.biotoday.com/post_comment.cfm?init=A109868&ref=rss [医学] 塩野義製薬のXocovaがコロナ伝染を減らしたPh3試験SCORPIO-PEP論文報告 http://www.biotoday.com/view.cfm?n=109867&ref=rss http://www.biotoday.com/view.cfm?n=109867&ref=rss ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM） biotoday@biotoday.com Sun, 17 May 2026 12:05:09 +0900 http://www.biotoday.com/post_comment.cfm?init=A109867&ref=rss [医学] 中血管閉塞脳卒中患者の力ずく血栓除去が内科治療のみに勝る http://www.biotoday.com/view.cfm?n=109866&ref=rss http://www.biotoday.com/view.cfm?n=109866&ref=rss ジャーナル / 総合医学誌 / New England Journal of Medicine（NEJM） biotoday@biotoday.com Sun, 17 May 2026 09:52:55 +0900 http://www.biotoday.com/post_comment.cfm?init=A109866&ref=rss [企業] AstraZeneca/第一三共のEnhertuの乳癌用途2つを米国承認 http://www.biotoday.com/view.cfm?n=109865&ref=rss http://www.biotoday.com/view.cfm?n=109865&ref=rss 開発 / 承認申請 / 承認取得 biotoday@biotoday.com Sun, 17 May 2026 08:13:15 +0900 http://www.biotoday.com/post_comment.cfm?init=A109865&ref=rss [企業] AmgenのTepezzaの領分を奪うはずだった甲状腺眼症薬からAlumisが手を引く http://www.biotoday.com/view.cfm?n=109864&ref=rss http://www.biotoday.com/view.cfm?n=109864&ref=rss ビジネス / 会社運営 / 業績発表・予想 biotoday@biotoday.com Sat, 16 May 2026 15:16:12 +0900 http://www.biotoday.com/post_comment.cfm?init=A109864&ref=rss [企業] 膀胱切除するも癌細胞が残る膀胱癌患者へのRocheのTecentriq使用を米国承認 http://www.biotoday.com/view.cfm?n=109863&ref=rss http://www.biotoday.com/view.cfm?n=109863&ref=rss 開発 / 承認申請 / 承認取得 biotoday@biotoday.com Sat, 16 May 2026 12:06:01 +0900 http://www.biotoday.com/post_comment.cfm?init=A109863&ref=rss [医学] 癌の疲労にメチルフェニデートの類いが有効 http://www.biotoday.com/view.cfm?n=109862&ref=rss http://www.biotoday.com/view.cfm?n=109862&ref=rss biotoday@biotoday.com Sat, 16 May 2026 11:03:00 +0900 http://www.biotoday.com/post_comment.cfm?init=A109862&ref=rss [医学] 妊婦のインフルエンザが特に有害なのはウイルス感知役TLR7の暴走のせいらしい http://www.biotoday.com/view.cfm?n=109861&ref=rss http://www.biotoday.com/view.cfm?n=109861&ref=rss biotoday@biotoday.com Sat, 16 May 2026 08:45:56 +0900 http://www.biotoday.com/post_comment.cfm?init=A109861&ref=rss [企業] AnthropicとGates Foundationが協力して健康、教育、農業のAI頼りの道具を作る http://www.biotoday.com/view.cfm?n=109860&ref=rss http://www.biotoday.com/view.cfm?n=109860&ref=rss ビジネス / 対外交渉 / 産学公民連携 biotoday@biotoday.com Sat, 16 May 2026 08:10:43 +0900 http://www.biotoday.com/post_comment.cfm?init=A109860&ref=rss [企業] Aardvark社がすでに自主停止した過食薬Ph3試験を米国FDAが差し止め http://www.biotoday.com/view.cfm?n=109859&ref=rss http://www.biotoday.com/view.cfm?n=109859&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 biotoday@biotoday.com Fri, 15 May 2026 16:56:32 +0900 http://www.biotoday.com/post_comment.cfm?init=A109859&ref=rss [企業] EyePoint社の長持ちなVEGF受容体阻害薬のWet AMD相手のPh3試験が関門通過 http://www.biotoday.com/view.cfm?n=109858&ref=rss http://www.biotoday.com/view.cfm?n=109858&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 biotoday@biotoday.com Fri, 15 May 2026 16:36:54 +0900 http://www.biotoday.com/post_comment.cfm?init=A109858&ref=rss [企業] Regenxbioのデュシェンヌ型筋ジストロフィー遺伝子治療のPh3試験目標達成 http://www.biotoday.com/view.cfm?n=109857&ref=rss http://www.biotoday.com/view.cfm?n=109857&ref=rss 開発 / 臨床試験 / 第3相/ピボタル試験 biotoday@biotoday.com Fri, 15 May 2026 13:41:56 +0900 http://www.biotoday.com/post_comment.cfm?init=A109857&ref=rss